…
Mercanto Holdings Inc. operates in cannabis and wellness industries in Canada and the United States. It engages in the production and sale of cannabis-based products and beverages. The company was formerly known as The Good Shroom Co Inc. and changed its name to Mercanto Holdings Inc. in February 2025. Mercanto Holdings Inc. is headquartered in Québec, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Good Shroom Co Inc. (MUSH.V) are limited, with exchange filings offering few verifiable details about operations. Investors must rely on future audited filings and management disclosures to evaluate long-term drivers such as revenue growth, production scalability and competitive positioning, which may support value if executed. Attractiveness will depend on clear commercial traction and governance transparency.
Primary risks are limited disclosure, lack of an established operating track record, low trading liquidity and significant execution and regulatory uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
| Income before tax | -0.41M | 0.04M | -0.45M | -1.63M | -3.85M |
| Net income | -0.41M | 0.04M | -0.45M | -1.63M | -3.85M |
| Selling general administrative | 0.98M | 1.15M | 1.09M | 1.76M | 3.45M |
| Gross profit | 0.62M | 1.23M | 0.67M | 0.23M | 0.06M |
| Reconciled depreciation | 0.02M | 0.02M | 0.02M | 0.06M | 0.06M |
| Ebit | - | - | - | -1.57M | -2.17M |
| Ebitda | - | - | - | -1.56M | -3.79M |
| Operating income | -0.41M | 0.05M | -0.45M | -1.61M | -3.48M |
| Other operating expenses | - | - | - | 0.01M | 0.03M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | -0.00M | -0.00M | -0.00M | -0.02M | -0.15M |
| Total revenue | 3.00M | 3.89M | 3.16M | 1.22M | 0.24M |
| Total operating expenses | 3.41M | 3.85M | 3.61M | 2.82M | 3.72M |
| Cost of revenue | 2.37M | 2.67M | 2.50M | 0.99M | 0.18M |
| Total other income expense net | -0.00M | -0.00M | -0.00M | -0.00M | -0.23M |
| Net income from continuing ops | -0.41M | 0.04M | -0.45M | -1.63M | -3.85M |
| Net income applicable to common shares | - | - | - | -1.63M | -3.85M |
| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
| Total assets | 1.02M | 1.48M | 1.44M | 1.64M | 2.30M |
| Total liab | 0.78M | 0.90M | 0.99M | 0.88M | 0.50M |
| Total stockholder equity | 0.24M | 0.58M | 0.46M | 0.76M | 1.80M |
| Other current liab | - | - | - | - | 0.05M |
| Common stock | - | - | - | 10.65M | 10.55M |
| Capital stock | 11.32M | 11.11M | 11.08M | 10.65M | 10.55M |
| Retained earnings | -13.17M | -12.76M | -12.80M | -12.34M | -10.71M |
| Other liab | - | - | - | 0.02M | 0.02M |
| Cash | 0.39M | 0.20M | 0.38M | 0.68M | 1.62M |
| Total current liabilities | 0.78M | 0.90M | 0.97M | 0.71M | 0.27M |
| Short long term debt | - | - | 0.04M | - | - |
| Property plant equipment | - | - | - | 0.20M | 0.26M |
| Total current assets | 1.00M | 1.45M | 1.39M | 1.45M | 2.04M |
| Net tangible assets | - | - | - | 0.76M | 1.80M |
| Short term investments | - | - | - | 0.07M | 0.07M |
| Net receivables | 0.18M | 0.68M | 0.53M | 0.24M | 0.09M |
| Long term debt | - | - | - | 0.04M | 0.04M |
| Inventory | 0.43M | 0.53M | 0.45M | 0.39M | 0.19M |
| Accounts payable | 0.78M | 0.88M | 0.89M | 0.45M | 0.08M |
| Non current assets total | 0.02M | 0.04M | 0.06M | 0.20M | 0.26M |
| Capital lease obligations | 0.00M | 0.02M | 0.03M | 0.17M | 0.22M |
| Breakdown | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
| Investments | - | 0.00M | 0.07M | 0.00M | -0.07M |
| Change to liabilities | - | - | - | 0.54M | 0.06M |
| Total cashflows from investing activities | - | - | - | - | 2.58M |
| Net borrowings | -0.02M | -0.06M | - | -0.16M | 0.24M |
| Total cash from financing activities | -0.02M | -0.03M | -0.02M | -0.16M | 0.25M |
| Change to operating activities | - | - | - | 0.00M | -0.01M |
| Net income | -0.41M | 0.04M | -0.45M | -1.63M | -3.85M |
| Change in cash | 0.19M | -0.18M | -0.30M | -0.94M | 1.11M |
| Begin period cash flow | 0.20M | 0.38M | 0.68M | 1.62M | 0.50M |
| End period cash flow | 0.39M | 0.20M | 0.38M | 0.68M | 1.62M |
| Total cash from operating activities | 0.21M | -0.15M | -0.36M | -0.78M | -1.71M |
| Depreciation | 0.02M | 0.02M | 0.02M | 0.06M | 0.06M |
| Change to inventory | 0.10M | -0.08M | -0.06M | -0.20M | -0.11M |
| Change to account receivables | - | -0.16M | -0.29M | -0.15M | -0.06M |
| Other cashflows from financing activities | - | - | - | - | -0.01M |
| Change to netincome | - | - | - | 0.60M | 2.17M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.02M |
| Change in working capital | 0.53M | -0.25M | -0.07M | 0.19M | -0.09M |
| Stock based compensation | 0.07M | 0.05M | 0.15M | 0.59M | 0.58M |
| Other non cash items | 0.00M | 0.00M | 0.00M | 0.01M | 1.59M |
| Free cash flow | 0.21M | -0.15M | -0.36M | -0.78M | -1.73M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MUSH Good Shroom Co Inc |
- -% |
0.11 | - | - | 1.73 | 21.02 | 1.57 | 3079.29 |
| RX Biosyent Inc. |
0.30 1.78% |
17.15 | 19.10 | 15.85 | 3.96 | 4.11 | 3.31 | 11.03 |
| DB Decibel Cannabis Company Inc |
0.21 11.67% |
2.01 | - | 8.67 | 0.67 | 1.20 | 0.99 | 17.75 |
| ZYUS ZYUS Life Sciences Corporation |
0.03 9.38% |
0.35 | - | - | 108.48 | 4.41 | 140.29 | -4.26 |
| LSL LSL Pharma Group Inc. |
0.01 1.64% |
0.31 | 20.75 | - | 1.88 | 1.89 | 2.85 | 10.19 |
Mercanto Holdings Inc. operates in cannabis and wellness industries in Canada and the United States. It engages in the production and sale of cannabis-based products and beverages. The company was formerly known as The Good Shroom Co Inc. and changed its name to Mercanto Holdings Inc. in February 2025. Mercanto Holdings Inc. is headquartered in Québec, Canada.
11 Beacon Street, Québec, QC, Canada, H9J 2E9
| Name | Title | Year Born |
|---|---|---|
| Mr. Eric Ronsse | Pres, CEO & Chairman | 1989 |
| Mr. Scott Jardin | Chief Financial Officer | 1978 |
| Ms. Anik Gendron | Corp. Sec. | 1971 |
| Mr. Eric Ronsse | President, CEO & Chairman | 1989 |
| Mr. Scott Jardin CPA, CGA | Chief Financial Officer | 1979 |
| Mr. Peter Ho | Operations Manager | NA |
| Ms. Anik Gendron | Corporate Secretary | 1971 |
| Mr. Eric Ronsse | President, CEO & Chairman | 1988 |
| Mr. Scott Jardin CPA, CGA | Chief Financial Officer | 1978 |
| Ms. Anik Gendron | Corporate Secretary | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.